Simon Douglas

Simon Douglas

Vermogen: 112 980 $ op 31-07-2026

68 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Dr. Simon G.
Douglas is a Chairman at EMQN CIC, a Non-Executive Chairman at C-Major Ltd. and a Non-Executive Chairman at Fusion Antibodies Plc.
Dr. Douglas was previously employed as a Non-Executive Chairman by Abselion Ltd., a Non-Executive Chairman by Cambridge Nutritional Sciences Plc, a Chief Executive Officer & Director by Biofortuna Ltd., an Executive Chairman by Lab901 Ltd., a Managing Director by Invitrogen Holdings Ltd., a Chief Executive Officer by DNA Research Innovations Ltd., a Chief Executive Officer by DRI Ltd. (United Kingdom), a Chief Executive Officer by Tepnel Life Sciences Plc, a Head-Technical & Marketing by ICI Group, a Project Leader by GE Healthcare Ltd. (United Kingdom), and a Manager-Business Development by Zeneca, Inc. He received his graduate degree from The University of Southampton and a doctorate degree from The University of Southampton.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
17-02-2026 861.062 ( 0,69% ) 112 980 $ 31-07-2026

Actieve functies van Simon Douglas

BedrijvenFunctieBegin
FUSION ANTIBODIES PLC Voorzitter 01-09-2011
Voorzitter 01-09-2019

Eerdere bekende functies van Simon Douglas

BedrijvenFunctieEinde
Voorzitter 23-03-2026
CAMBRIDGE NUTRITIONAL SCIENCES PLC Voorzitter 22-04-2024
Algemeen Directeur 01-01-2019
Voorzitter 01-01-2011
Algemeen Directeur 01-01-2006
Ervaring van Simon Douglas in detail bekijken

Opleiding van Simon Douglas

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

25

Eerstegraads connecties

14

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit14

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Process Industries

Zeneca, Inc.

Health Services

Finance

Commercial Services

Technology Services

Health Technology

DRI Ltd. (United Kingdom)

  1. Beurs
  2. Insiders
  3. Simon Douglas